Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02874261 · ClinicalTrials.gov registry record · NA

Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

A NA study of Physical Activity and Sleep Disorders, sponsored by New York Institute of Technology.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02874261: Completed NA study of Physical Activity and Sleep Disorders, sponsored by New York Institute of Technology.

NCT02874261 is a NA study of Physical Activity and Sleep Disorders that has completed, run by New York Institute of Technology. The registered enrollment target is 10 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02874261, a NA study of Physical Activity and Sleep Disorders, has completed, sponsored by New York Institute of Technology.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." The frequency of the translation (up to 180 cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by the patient or health care professional. The science behind the therapeutic effects of WBPA still remains largely unknown. The investigators are observing how WBPA may impact on sleep and activity in individuals with Parkinson's disease.

Primary Outcome

The investigators will record sleep patterns a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

Interventions

  • DEVICE Whole Body Periodic Acceleration

Study Locations (1)

New York

  • NYIT - Old Westbury

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-05
Est. Completion 2017-06
Phase NA
New York Institute of Technology

49 total trials

What the finished NCT02874261 record still lists

NCT02874261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Physical Activity appearing as the primary indexed condition, and to 1 intervention - of which Whole Body Periodic Acceleration is the first listed.

NCT02874261 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02874261 about?

NCT02874261 is a clinical study titled "Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease". Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along th...

What is the current status of trial NCT02874261?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-05. Estimated completion is 2017-06.

What conditions does trial NCT02874261 study?

This clinical trial studies the following conditions: Physical Activity, Sleep Disorders.

What interventions are being tested in trial NCT02874261?

The interventions under investigation include: Whole Body Periodic Acceleration (DEVICE).

Who is sponsoring clinical trial NCT02874261?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02874261 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02874261's enrollment target sits among peer trials

10 130th of 131 higher than 2 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02874261, the US trial registry maintained by the National Library of Medicine. NCT02874261 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.